PomDoctor (NASDAQ: POM) saw its stock price surge 12.50% in intraday trading on Wednesday, as the company made its debut on the Nasdaq stock exchange. The significant uptick comes on the heels of the company's initial public offering (IPO) announcement, which has garnered substantial investor interest.

According to the company's statement, PomDoctor has priced its IPO at $4.00 per American Depositary Share (ADS). The offering consists of 5,000,004 ADSs, which is expected to raise approximately $20 million in gross proceeds. This successful pricing and the subsequent listing on a major U.S. exchange appear to be driving the stock's impressive performance in its first day of trading.

The IPO also includes an option for underwriters to purchase up to an additional 750,000 ADSs, potentially increasing the total capital raised. With its shares now trading under the ticker symbol "POM", PomDoctor's strong market debut suggests positive investor sentiment towards the company's future prospects. As the trading session progresses, market participants will be closely watching to see if the stock can maintain its early momentum.